Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly A Cattaneo, N Cattane, S Galluzzi, S Provasi, N Lopizzo, C Festari, ... Neurobiology of aging 49, 60-68, 2017 | 1110 | 2017 |
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ... Scientific reports 7 (1), 41802, 2017 | 782 | 2017 |
Germ‐free C57BL/6J mice are resistant to high‐fat‐diet‐induced insulin resistance and have altered cholesterol metabolism S Rabot, M Membrez, A Bruneau, P Gérard, T Harach, M Moser, ... The FASEB Journal 24 (12), 4948-4959, 2010 | 744 | 2010 |
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading TWH Pols, M Nomura, T Harach, GL Sasso, MH Oosterveer, C Thomas, ... Cell metabolism 14 (6), 747-757, 2011 | 573 | 2011 |
Porphyrias UA Meyer Harrison's principles of internal medicine, 1829-1834, 1991 | 194 | 1991 |
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins T Harach, TWH Pols, M Nomura, A Maida, M Watanabe, J Auwerx, ... Scientific reports 2 (1), 430, 2012 | 192 | 2012 |
Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis PJ Fernandez-Marcos, EH Jeninga, C Canto, T Harach, VCJ De Boer, ... Scientific reports 2 (1), 425, 2012 | 144 | 2012 |
LRH-1–dependent glucose sensing determines intermediary metabolism in liver MH Oosterveer, C Mataki, H Yamamoto, T Harach, N Moullan, ... The Journal of clinical investigation 122 (8), 2817-2826, 2012 | 125 | 2012 |
Lo Sasso G, Oosterveer MH, Thomas C, Rizzo G, Gioiello A, Adorini L, Pellicciari R, Auwerx J, Schoonjans K. TGR5 activation inhibits atherosclerosis by reducing macrophage … TW Pols, M Nomura, T Harach Cell Metab 14 (6), 747-757, 2011 | 98 | 2011 |
Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet T Harach, O Aprikian, I Monnard, J Moulin, M Membrez, JC Béolor, ... Planta medica 76 (06), 566-571, 2010 | 98 | 2010 |
Role of TGR5 (GPBAR1) in liver disease V Keitel, D Häussinger Seminars in liver disease 38 (04), 333-339, 2018 | 89 | 2018 |
Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease T Harach, F Jammes, C Muller, N Duthilleul, V Cheatham, V Zufferey, ... Neurobiology of aging 51, 83-96, 2017 | 82 | 2017 |
Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice [S] C Thabuis, F Destaillats, DM Lambert, GG Muccioli, M Maillot, T Harach, ... Journal of lipid research 52 (7), 1373-1382, 2011 | 49 | 2011 |
lo Sasso TW Pols, M Nomura, T Harach G, 0 | 47 | |
Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota T Harach, N Marungruang, N Dutilleul, V Cheatham, KD Mc Coy, ... arXiv preprint arXiv:1509.02273, 2015 | 38 | 2015 |
Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ... Scientific reports 7 (1), 46856, 2017 | 32 | 2017 |
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep. 2017; 7: 41802 T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ... Epub 2017/02/09. https://doi. org/10.1038/srep41802 PMID: 28176819, 1802 | 25 | 1802 |
Gastro-Intestinal Biomarkers for Diagnosis and Therapies of Proteinopathies T Lasser, T Bolmont, T Harach, W Hanna, F Fåk, N Marungruang US Patent App. 15/541,045, 2017 | | 2017 |
Use of waste products for detecting amyloidogenic proteinaceous material in living mammals T Bolmont, P Fraering, T Lasser, M Dimtrov, T Harach | | 2013 |
Crossroads between drug and energy metabolism: role of constitutive androstane receptor and AMP-activated kinase T Harach University_of_Basel, 2010 | | 2010 |